Randomized Phase II Study of Cetuximab in Combination With Gemcitabine or Gemcitabine Followed by Cetuximab in Advanced Non Small-Cell Lung Cancer Patients Who Are Not Candidates for Platinum Based Therapy.

Trial Profile

Randomized Phase II Study of Cetuximab in Combination With Gemcitabine or Gemcitabine Followed by Cetuximab in Advanced Non Small-Cell Lung Cancer Patients Who Are Not Candidates for Platinum Based Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2012

At a glance

  • Drugs Cetuximab; Gemcitabine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms CALC1; CALC1-E; CALC1-PS2
  • Most Recent Events

    • 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Sep 2008 Results reported at ESMO 2008.
    • 29 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top